FDA Approves First Blood Test for Colorectal Cancer Screening

The U.S. FDA has approved SimpleScreen CRC, the first blood-based screening test for colorectal cancer in average-risk adults aged 45 and older. Commercialized by Abbott, this new, less invasive option for early detection demonstrated 81.1% sensitivity in clinical studies. This approval offers a significant alternative to existing screening methods, potentially increasing adherence to crucial early detection guidelines for colorectal cancer.